" class="no-js "lang="en-US"> Robin Swann Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

New UK-wide Ambitions to Accelerate Genomic Research and Drive Innovation in Healthcare

Patients across the UK are set to benefit from faster cancer diagnosis and innovative new […]

£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery

Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]

New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation

Increasing consent rates for organ donation and making the most of donated organs for transplant […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more